Laboratory equipment manufacturer Asynt has introduced an expanded portfolio of photochemistry reactors, offering researchers enhanced capabilities for both batch and continuous flow applications. This development addresses the growing interest in photochemistry as a ‘reagentless’ activation method in synthetic chemistry.

The CE-marked assay provides fast and simple real-time PCR-based detection of SARS-CoV-2 in RNA isolated from the patient samples. Reverse transcription and real-time PCR are performed in one step, so that only one reaction is required per sample.

Edinburgh-based laser manufacturer Chromacity Ltd has demonstrated that its Model 1040 ultrafast fibre laser can generate exceptionally broad and flat supercontinua in the near-infrared region, spanning 750-1300 nm. The development has significant implications for medical imaging and spectroscopy applications.

AMSBIO has launched a comprehensive kit containing all variants of their recombinant laminin E8 fragments, designed to support researchers working with embryonic stem (ES) and induced pluripotent stem (iPS) cells. The iMatrix Palette aims to streamline protocol development for cell culture and differentiation applications.

Becton, Dickinson and Company (BD) has announced a strategic collaboration with Swiss injection systems developer Ypsomed to address the technical challenges of delivering high-viscosity biologic drugs. The partnership combines BD’s latest prefillable syringe technology with Ypsomed’s autoinjector platform to facilitate the administration of biologics with viscosities exceeding 15 centipoise (cP).